Department of Biomaterials, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
J Ocul Pharmacol Ther. 2021 Apr;37(3):172-180. doi: 10.1089/jop.2020.0134. Epub 2021 Jan 26.
The intraocular lens (IOL) is a common, yet important, implantable device used in treatment of cataract in clinics. However, the unexpected adhesion of postoperative residual lens epithelial cells (LECs) often causes serious complications, such as posterior capsular opacification (PCO), which lead to vision loss again. In this investigation, a poly(sulfobetaine methacrylate) (PSBMA) brush coating was fabricated on an IOL to generate a hydrophilic surface coating on the IOL for enhanced cell adhesion resistance so as to decrease PCO incidence. The PSBMA brush coating on the IOL surface was fabricated using surface-initiated reversible addition-fragmentation chain transfer polymerization. X-ray photoelectron spectroscopy (XPS) was used to demonstrate the surface coating preparation. The water contact angle (WCA) measurement was used to test surface hydrophilicity. LEC culture was use to evaluate the cell behavior on the IOL material surfaces, with or without PSBMA coating modification. Finally, animal cataract surgeries were carried out to evaluate biocompatibilities and anti-PCO effects. The XPS and WCA measurements illustrate successful surface modification and good surface hydrophilicity. The cell culture results show that the hydrophilic PSBMA polymer brush coating evidently decreases adhesion and proliferation of LECs. Results of the cataract surgery with intraocular implantation show that PSBMA modification on the IOL surface does not induce side effects in nearby tissues, whereas posterior capsular hyperplasia can be evidently reduced. The PSBMA brush surface-modified IOL has good biocompatibility and it can effectively reduce the incidence of postoperative PCO.
人工晶状体 (IOL) 是临床治疗白内障的常用且重要的植入物。然而,术后残留晶状体上皮细胞 (LEC) 的意外黏附常常导致严重的并发症,如后发性白内障 (PCO),从而导致视力再次丧失。在这项研究中,在 IOL 上制备了聚(磺酸甜菜碱甲基丙烯酸酯) (PSBMA) 刷状涂层,以在 IOL 上生成亲水性表面涂层,从而增强细胞抗黏附性,降低 PCO 的发生率。通过表面引发可逆加成-断裂链转移聚合在 IOL 表面制备 PSBMA 刷状涂层。X 射线光电子能谱 (XPS) 用于证明表面涂层的制备。水接触角 (WCA) 测量用于测试表面亲水性。通过 LEC 培养来评估细胞在 IOL 材料表面的行为,有无 PSBMA 涂层修饰。最后,进行动物白内障手术以评估生物相容性和抗 PCO 效果。XPS 和 WCA 测量结果表明成功的表面改性和良好的表面亲水性。细胞培养结果表明,亲水 PSBMA 聚合物刷状涂层明显降低了 LEC 的黏附和增殖。眼内植入的白内障手术结果表明,IOL 表面的 PSBMA 改性不会在附近组织中引起副作用,而后囊膜增生可明显减少。PSBMA 刷状表面改性的 IOL 具有良好的生物相容性,可有效降低术后 PCO 的发生率。